日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease

对支持以β-淀粉样蛋白减少作为阿尔茨海默病替代终点的证据进行综述

Chen, Tianle; Hutchison, R Matthew; Rubel, Carrie; Murphy, Jennifer; Xie, Jing; O'Gorman, John; Dent, Gersham; Molenberghs, Geert; Sormani, Maria Pia; Hendrix, Suzanne; Hansson, Oskar; Aisen, Paul; Haeberlein, Samantha Budd; Tian, Ying

Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease

西莫菲拉姆治疗轻度至中度阿尔茨海默病的3期随机临床试验

Kupiec, James W; Porsteinsson, Anton P; Turner, Raymond S; Hendrix, Suzanne; Mallinckrodt, Craig; Khan, Arifulla; Cohen, Ian; Liss, Jonathan; Clarnette, Roger; Park, Kee Hyung; Hernandez, Antonio M; Burns, Lindsay H

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials

磁共振成像中海马萎缩作为早期症状性阿尔茨海默病临床获益和神经退行性变的替代标志物:观察性和干预性试验证据的综合分析

Abushakra, Susan; Doraiswamy, P Murali; Hey, John A; Tosun, Duygu; Barkhof, Frederik; Barakos, Jerome; Petrella, Jeffrey; Kesslak, J Patrick; Power, Aidan; Sabbagh, Marwan; Porsteinsson, Anton; Cohen, Sharon; Gauthier, Serge; Ritchie, Craig; Watson, David; McSweeney, Emer; Boada, Merce; Liang, Earvin; Bracoud, Luc; McLaine, Rosalind; Flint, Susan; Schaefer, Jean F; Yu, Jeremy; Bray, Margaret; Hendrix, Suzanne; Dickson, Sam; Durrant, Abe; Albayrak, Adem; Tolar, Martin

Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)

将患者视角纳入综合评分以衡量脊髓小脑性共济失调(SCA)的疾病进展

Potashman, Michele H; Rogula, Basia M; Powell, Lauren C; Korol, Ellen E; Dickson, Sam P; Hendrix, Suzanne; Heinrich, Maggie; Rudell, Katja; Abetz-Webb, Linda; Beiner, Melissa W; Coric, Vlad; Rosenthal, Liana S; Perlman, Susan L; Schmahmann, Jeremy D; L'Italien, Gil

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease

一项随机2a期试验评估了一种新型隔蛋白分子胶在阿尔茨海默病中的应用

Nuytten, Mieke; Voets, Marieke; Debroux, Eveline; Princen, Katrien; Pringels, Lentel; Fivaz, Marc; Byl, Eline; Ramael, Steven; De Witte, Koen; Boada, Mercé; Morató, Xavier; Tartari, Juan Pablo; Lafuente, Asunción; Macias, Emilio Franco; Matias-Guiu, Jordi A; Vijverberg, Everard; Teunissen, Charlotte E; Anderer, Peter; Staggs, Vincent; Hayman, Vincent; Corbett, Anne; Ballard, Clive; Harrison, John E; Windisch, Manfred; Westman, Ann Brinkmalm; Zetterberg, Henrik; Dickson, Sam; Mallinckrodt, Craig; Hendrix, Suzanne; Cummings, Jeffrey; Griffioen, Gerard

The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trials

近期获批药物对未来阿尔茨海默病临床研发的影响:联合用药试验的统计学考量

Dickson, Samuel P; Mallinckrodt, Craig; Burstein, Aaron H; Nisenbaum, Laura; Fillit, Howard M; Zhang, Chenge; Hendrix, Suzanne B

Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation

阿尔茨海默病临床试验中联合疗法的关键考量因素:来自阿尔茨海默病药物研发基金会召集的专家顾问委员会的观点

Cummings, Jeffrey; Gold, Michael; Mintun, Mark; Irizarry, Michael; von Eschenbach, Andrew; Hendrix, Suzanne; Berry, Donald; Sampaio, Cristina; Sink, Kaycee; Landen, Jaren; Kivipelto, Miia; Grundman, Michael; Arnold, Steven E; Green, Allan; Partrick, Katherine; Nisenbaum, Laura; Burstein, Aaron; Fillit, Howard

A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease

一项针对帕金森病患者的昼夜节律有效光疗法的双盲对照试验

Wyman, Bradley T; Adams, Dan; Hendrix, Suzanne; Groves, Jeffrey; Croft, Wayne; Ellison, Noel; Olanow, C Warren; Kieburtz, Karl

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease.

对轻度阿尔茨海默病 1 期衰老细胞清除试验中探索性体液生物标志物的评估

Garbarino Valentina R, Palavicini Juan Pablo, Melendez Justin, Barthelemy Nicolas R, He Yingxin, Kautz Tiffany F, Lopez-Cruzan Marisa, Mathews Julia J, Xu Peng, Zhang Bin, Saliba Afaf, Ragi Nagarjunachary, Sharma Kumar, Mason Dallin, Johnson Samuel, Hendrix Suzanne, Craft Suzanne, Petersen Ronald C, Espindola-Netto Jair Machado, Xue Ailing, Tchkonia Tamara, Kirkland James L, Salardini Arash, Musi Nicolas, Bateman Randall J, Gonzales Mitzi M, Orr Miranda E

Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease

利用血浆生物标志物的最新进展来优化阿尔茨海默病早期概念验证试验

Duncan, Garrett B; Dickson, Samuel P; Kaplan, Johanne M; Johnson, Samuel B; Duke, Tyler M; Dayley, Caleb W; Hendrix, Suzanne B; Altstiel, Larry D; Mallinckrodt, Craig H